An webinar dedicated to IMI-2 Call 23 was organised to help and support potential participants from Turkey to Innovative Medicines Initiative (IMI).
Innovative Medicines Initiative (IMI), is working to improve health by speeding up the development of, and patient access to, innovative medicines, particularly in areas where there is an unmet medical or social need. It is a partnership between the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations). Through the IMI2 programme, €3.3 billion are available for the period 2014-2020.
Webinar Agenda and Materials